✦ Clinical Takeaway ✦
No actionable clinical change at this time; this is preliminary molecular characterization of rare non-vestibular intracranial schwannomas with no direct management guidance yet.
✦ Why It Matters ✦
Identifying distinct gene fusions in non-vestibular intracranial schwannomas could refine tumor classification and eventually inform targeted diagnostic or therapeutic approaches relevant to neurotology.
✦ Key Points ✦
- 01Two novel gene fusions — TANC1::HTRA1 and KPNA4::WWTR1 — identified in non-vestibular intracranial schwannomas.
- 02Published as a brief report in Acta Neuropathologica (2026), a high-impact neuropathology journal.
- 03Findings distinguish these tumors molecularly from vestibular schwannomas (acoustic neuromas).
- 04Molecular subtyping may improve diagnostic accuracy for this rare tumor subgroup.
- 05No abstract available; full characterization of sample size and methods is limited.
✦ Claims & Evidence ✦
ClaimEvidenceSupport
TANC1::HTRA1 gene fusions are present in non-vestibular intracranial schwannomas.
studyunclearKPNA4::WWTR1 gene fusions are present in non-vestibular intracranial schwannomas.
studyunclear✦ Research metadata ✦
- PMID
- 42201401
- DOI
- 10.1007/s00401-026-03032-3.
- Journal
- Acta Neuropathologica
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with non-vestibular intracranial schwannomas
- Intervention
- Molecular/genomic profiling for gene fusions (TANC1::HTRA1, KPNA4::WWTR1)
Primary outcomes
Identification of gene fusions in non-vestibular intracranial schwannomas